LEO 80185 Gel (Calcipotriol Hydrate Plus Betamethasone Dipropionate) in Japanese Subjects With Psoriasis

PHASE3CompletedINTERVENTIONAL
Enrollment

213

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
Psoriasis Vulgaris
Interventions
DRUG

LEO 80185 gel

calcipotriol hydrate 52.2 µg/g \[equivalent to 50.0 µg/g calcipotriol\] plus betamethasone dipropionate 0.643 mg/g, applied once daily to psoriasis lesions

DRUG

Dovobet ® ointment

calcipotriol hydrate 52.2 µg/g \[equivalent to 50.0 µg/g calcipotriol\] plus betamethasone dipropionate 0.643 mg/g, applied once daily to psoriasis lesions

Trial Locations (1)

090-0832

Medical Corporation Bikyukai Kokubu Dermatology, Kitami-shi

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

CMIC Co, Ltd. Japan

INDUSTRY

lead

LEO Pharma

INDUSTRY